PF-04171327 25 mg

DRUG2 trials

Sponsors

Pfizer

Conditions

Healthy VolunteersRheumatoid Arthritis

Phase 1

A Midazolam Drug Interaction Study With PF-04171327

CompletedNCT00987038

PfizerHealthy Volunteers

Start: 2009-09-30End: 2009-12-31Updated: 2009-12-08

Phase 2

A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis

CompletedNCT00938587

PfizerRheumatoid Arthritis

Start: 2009-10-07End: 2010-07-29Updated: 2023-11-22

Related Papers

In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF‐00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor

Clinical Pharmacology in Drug Development2017-11-075 citations

Population Pharmacokinetics of Fosdagrocorat (PF‐04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis

Clinical and Translational Science2017-11-049 citations

Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.

2017-03-2222 citations